PlainRecalls
FDA Drug Moderate Class II Terminated

Montelukast Sodium Tablets, USP, 10 mg Tablets, Rx Only, Packaged as: a) 30-count bottle, NDC 61919-0009-30; b) 90-count bottle, NDC 61919-0009-90; Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534

Reported: April 5, 2023 Initiated: March 13, 2023 #D-0476-2023

Product Description

Montelukast Sodium Tablets, USP, 10 mg Tablets, Rx Only, Packaged as: a) 30-count bottle, NDC 61919-0009-30; b) 90-count bottle, NDC 61919-0009-90; Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534

Reason for Recall

cGMP deviations

Details

Recalling Firm
Direct Rx
Units Affected
90 count: 495 bottles; 30 count: 13 bottles
Distribution
Nationwide in the USA
Location
Dawsonville, GA

Frequently Asked Questions

What product was recalled?
Montelukast Sodium Tablets, USP, 10 mg Tablets, Rx Only, Packaged as: a) 30-count bottle, NDC 61919-0009-30; b) 90-count bottle, NDC 61919-0009-90; Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534. Recalled by Direct Rx. Units affected: 90 count: 495 bottles; 30 count: 13 bottles.
Why was this product recalled?
cGMP deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on April 5, 2023. Severity: Moderate. Recall number: D-0476-2023.